Human Papillomavirus (HPV) Prevention and Control: The Way Forward
Esculapio · 31.12.2025 · 21 (04) · 1-2
DOI: 10.51273/esc25.251321256 ↗Kurz gefasst
Fachartikel in der Zeitschrift Esculapio, online erschienen am 31.12.2025. Verfasst von Prof Dr Muhammad Shoaib. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
The most prevalent Sexually Transmitted Diseasesand the primary cause of cervical cancer, which killsover 340,000 people a year, mostly in low- andmiddle-income countries (LMICs), is the humanpapillomavirus (HPV).1 Cervical cancer still posesa significant burden even with the availability ofefficient vaccinations and screening instruments.Despite being the third most common cancer inPakistan among women, there is still an alarming lackof awareness, immunization, and screening.6,7 Tocombat this avoidable illness, the World HealthOrganization (WHO) has suggested the 90–70–90elimination strategy.1 This editorial emphasizesinternational developments, Pakistan-specificdifficulties, and a realistic path forward.
Zitieren
APA
Shoaib, P. D. M. (2025). Human Papillomavirus (HPV) Prevention and Control: The Way Forward. Esculapio, 21(04), 1-2. https://doi.org/10.51273/esc25.251321256
Vancouver
Shoaib PDM. Human Papillomavirus (HPV) Prevention and Control: The Way Forward. Esculapio. 2025;21(04):1-2. doi:10.51273/esc25.251321256
BibTeX
@article{Shoaib2025,
author = {Shoaib, Prof Dr Muhammad},
title = {Human Papillomavirus (HPV) Prevention and Control: The Way Forward},
journal = {Esculapio},
year = {2025},
volume = {21},
number = {04},
pages = {1--2},
doi = {10.51273/esc25.251321256}
}
EUVIMED